{'headline': 'Bitcoin, Dogecoin Trail These 2024 Crypto Champions: Here Are The Top Performers Of The Year', 'url': 'https://www.benzinga.com/24/12/42717267/2024s-cryptocurrency-champions-these-top-performers-surpass-bitcoin-in-a-year-of-unprecedented-gains', 'summary': 'The cryptocurrency landscape witnessed a remarkable transformation in 2024, with several coins attracting traders&#39; attention due to their meteoric gains.', 'created date': datetime.datetime(2024, 12, 30, 5, 18, 9, tzinfo=datetime.timezone.utc), 'symbols': ['BTC', 'BTCUSD', 'DOGEUSD', 'ETHUSD', 'PEPEUSD', 'SOLUSD', 'XRPUSD']}
{'headline': 'Garden Stage Faces Nasdaq Delisting Risk, Given Six Months to Comply', 'url': 'https://www.benzinga.com/government/24/12/42717467/garden-stage-faces-nasdaq-delisting-risk-given-six-months-to-comply', 'summary': 'Garden Stage Limited (NASDAQ:GSIW) (&#34;GSIW&#34; or the &#34;Company&#34;), today announced that it received a delinquency notification letter (the &#34;Notice&#34;) from the Listing Qualifications Department of The Nasdaq Stock Market LLC', 'created date': datetime.datetime(2024, 12, 30, 6, 55, 8, tzinfo=datetime.timezone.utc), 'symbols': ['GSIW']}
{'headline': 'Reported Earlier, Faraday Future To Kick Off 2025 With FF 91 2.0 Futurist Alliance Delivery To Entrepreneur Luke Hans In Los Angeles', 'url': 'https://www.benzinga.com/news/24/12/42717476/reported-earlier-faraday-future-to-kick-off-2025-with-ff-91-2-0-futurist-alliance-delivery-to-entrep', 'summary': 'Luke Hans, the Company&#39;s latest Developer Co-Creation Officer, will receive his FF 91 2.0 Futurist Alliance during a delivery ceremony next month in Los Angeles with Company executives.', 'created date': datetime.datetime(2024, 12, 30, 6, 57, 59, tzinfo=datetime.timezone.utc), 'symbols': ['FFIE']}
{'headline': 'Reported Earlier, CEL-SCI Prices $5M Public Offering 16.13M Common Shares At $0.31/Share', 'url': 'https://www.benzinga.com/news/24/12/42717481/reported-earlier-cel-sci-prices-5m-public-offering-16-13m-common-shares-at-0-31share', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 6, 59, 58, tzinfo=datetime.timezone.utc), 'symbols': ['CVM']}
{'headline': 'Reported Earlier, WISeKey&#39;s SEALCOIN To Launch Space-Enabled M2M Transactions With New Wisesat Satellites In 2025', 'url': 'https://www.benzinga.com/news/24/12/42717529/reported-earlier-wisekeys-sealcoin-to-launch-space-enabled-m2m-transactions-with-new-wisesat-satelli', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 7, 11, 9, tzinfo=datetime.timezone.utc), 'symbols': ['WKEY']}
{'headline': 'Nvidia Tops Tesla As Better Bet Over 10 Years, Says Ross Gerber: Must Have In Portfolio Along With These 2 Stocks', 'url': 'https://www.benzinga.com/markets/equities/24/12/42717543/nvidia-tops-tesla-as-better-bet-over-10-years-says-ross-gerber-must-have-in-portfolio-along-with-these-2-stocks', 'summary': 'Nvidia Corp. has proven to be a more lucrative investment than Tesla Inc. over the past decade, according to Ross Gerber, CEO of Gerber Kawasaki Wealth &amp; Investment Management, who recommends treating the chipmaker as a core portfolio holding alongside tech giants.', 'created date': datetime.datetime(2024, 12, 30, 7, 21, 51, tzinfo=datetime.timezone.utc), 'symbols': ['AAPL', 'MSFT', 'NVDA', 'SPY', 'TSLA']}
{'headline': 'Reported Earlier, Telix Submits Biologics License Application To FDA Application For TLX250-CDx (Zircaix)', 'url': 'https://www.benzinga.com/news/24/12/42717559/reported-earlier-telix-submits-biologics-license-application-to-fda-application-for-tlx250-cdx-zirca', 'summary': 'The FDA is expected to advise the PDUFA4 goal date following the 60-day administrative review of the application.', 'created date': datetime.datetime(2024, 12, 30, 7, 25, 47, tzinfo=datetime.timezone.utc), 'symbols': ['TLX']}
{'headline': 'Reported Sunday, IDEAYA Biosciences Secures Global License For SHR-4849, A Novel Phase 1 DLL3-Targeting ADC For SCLC And NET Tumors', 'url': 'https://www.benzinga.com/news/24/12/42717749/reported-sunday-ideaya-biosciences-secures-global-license-for-shr-4849-a-novel-phase-1-dll3-targetin', 'summary': 'Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug conjugate (ADC)DLL3 highly expressed in Small Cell Lung Cancer (SCLC) and Neuroendocrine Tumors', 'created date': datetime.datetime(2024, 12, 30, 7, 33, 23, tzinfo=datetime.timezone.utc), 'symbols': ['IDYA']}
{'headline': 'Chamath Palihapitiya Says S&amp;P 500 index ETFs Need To Be &#39;Fixed&#39; Or They Will End In &#39;Disaster&#39; — Here Is What The Billionaire Investor Said', 'url': 'https://www.benzinga.com/etfs/broad-u-s-equity-etfs/24/12/42717758/chamath-palihapitiya-says-sp-500-index-etfs-need-to-be-fixed-or-they-will-end-in-disaster-here-is-what-the-billionaire-investor-said', 'summary': 'ETF Investors could be &#34;in for a rude awakening,&#34; says Chamath Palihapitiya as top ten stocks in S&amp;P 500 represent 40% of the capitalization.', 'created date': datetime.datetime(2024, 12, 30, 7, 33, 53, tzinfo=datetime.timezone.utc), 'symbols': ['AAPL', 'AMZN', 'AVGO', 'BRK', 'GOOG', 'GOOGL', 'META', 'MSFT', 'NVDA', 'RSP', 'SPY', 'TSLA']}
{'headline': 'Reported Friday, Four Corners Property Trust Acquires Burger King Property For $1.7M, Closes 2024 With $265M In Acquisitions', 'url': 'https://www.benzinga.com/news/24/12/42717769/reported-friday-four-corners-property-trust-acquires-burger-king-property-for-1-7m-closes-2024-with', 'summary': 'Including today&#39;s acquisition, FCPT completed real estate acquisitions of 87 properties in 2024 for a total investment of approximately $265 million, exclusive of transaction costs.&#34;We ended 2024 with our busiest four', 'created date': datetime.datetime(2024, 12, 30, 7, 35, 50, tzinfo=datetime.timezone.utc), 'symbols': ['FCPT']}
{'headline': 'Nvidia Was Blue Chip Star Of 2024, But Trailblazers In the Small Cap Universe Charted Exhilarating Gains — Here Are The Chart Toppers', 'url': 'https://www.benzinga.com/markets/equities/24/12/42717777/nvidia-was-blue-chip-star-of-2024-but-trailblazers-in-the-small-cap-universe-charted-exhilarating-gains-here-are-the-chart-toppers', 'summary': 'Small-cap stocks emerged as the standout performers of 2024, significantly outpacing their blue-chip counterparts amid a broader market rally. ', 'created date': datetime.datetime(2024, 12, 30, 7, 40, 59, tzinfo=datetime.timezone.utc), 'symbols': ['APP', 'AXP', 'COST', 'DAVE', 'KULR', 'MSTR', 'NVDA', 'PLTR', 'QMCO', 'RCAT', 'SEZL', 'WFC', 'WMT']}
{'headline': 'Elon Musk Rejects UK As A Possible Gigafactory Location', 'url': 'https://www.benzinga.com/tech/24/12/42717793/elon-musk-rejects-uk-as-a-possible-gigafactory-location', 'summary': 'Elon Musk dismissed the chances of his EV company putting up a factory in the UK, saying that few companies will be willing to invest in the country under the current administration.', 'created date': datetime.datetime(2024, 12, 30, 7, 45, 11, tzinfo=datetime.timezone.utc), 'symbols': ['TSLA']}
{'headline': 'Bitcoin Set For January Spike? Historical Patterns Signal A Potential Peak Next Month', 'url': 'https://www.benzinga.com/markets/cryptocurrency/24/12/42717805/bitcoin-set-for-january-spike-historical-patterns-signal-a-potential-peak-next-month', 'summary': 'Bitcoin (CRYPTO: BTC) is expected to reach a new all-time high in mid-January, according to a prediction by research firm\xa0K33. This anticipated peak coincides with the inauguration of\xa0Donald Trump.', 'created date': datetime.datetime(2024, 12, 30, 7, 50, 31, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD']}
{'headline': 'Himax To Unveil Next-Gen Biometric Tech for Smart Locks at CES 2025', 'url': 'https://www.benzinga.com/news/24/12/42717815/himax-to-unveil-next-gen-biometric-tech-for-smart-locks-at-ces-2025', 'summary': 'Himax Technologies, Inc. (&#34;Himax&#34; or &#34;Company&#34;) (NASDAQ:HIMX), an industry leader in fabless display driver ICs and other semiconductors, today announced the Company will introduce its expanded WiseEyeTM PalmVein suite', 'created date': datetime.datetime(2024, 12, 30, 7, 51, 52, tzinfo=datetime.timezone.utc), 'symbols': ['HIMX']}
{'headline': 'Reported Friday, Bristol Myers Squibb Receives FDA Approval For Opdivo Qvantig, The First Subcutaneous PD-1 Therapy', 'url': 'https://www.benzinga.com/news/24/12/42717834/reported-friday-bristol-myers-squibb-receives-fda-approval-for-opdivo-qvantig-the-first-subcutaneous', 'summary': 'Opdivo Qvantig is the first and only subcutaneously administered PD-1 inhibitor1Given over three- to five-minutes, Opdivo Qvantig demonstrated consistent efficacy and showed a comparable safety profile to intravenous', 'created date': datetime.datetime(2024, 12, 30, 8, 0, 12, tzinfo=datetime.timezone.utc), 'symbols': ['BMY']}
{'headline': 'VEON And Starlink Partner To Launch Direct-To-Cell Satellite Connectivity For Kyivstar Customers In Ukraine', 'url': 'https://www.benzinga.com/news/24/12/42717848/veon-and-starlink-partner-to-launch-direct-to-cell-satellite-connectivity-for-kyivstar-customers-in', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 8, 6, 55, tzinfo=datetime.timezone.utc), 'symbols': ['VEON']}
{'headline': 'CCSC Technology International, CEL-SCI And 3 Stocks To Watch Heading Into Monday', 'url': 'https://www.benzinga.com/24/12/42717849/ccsc-technology-international-cel-sci-and-3-stocks-to-watch-heading-into-monday', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 8, 9, 17, tzinfo=datetime.timezone.utc), 'symbols': ['CCTG', 'CTXR', 'CVM', 'GNS', 'LUNA']}
{'headline': 'Reported Friday, Genius Group H1 Revenue $4.9M Down From $11.8M YoY, EPS ($0.84) Up From ($3.20) YoY', 'url': 'https://www.benzinga.com/news/earnings/24/12/42717886/reported-friday-genius-group-h1-revenue-4-9m-down-from-11-8m-yoy-eps-0-84-up-from-3-20-yoy', 'summary': 'Financial Highlights for the First Half of 2024●First half revenue of $4.9 million, compared to $11.8 million for first half of 2023, due to the spin off of Entrepreneur Resorts Limited and closure of University of', 'created date': datetime.datetime(2024, 12, 30, 8, 22, 48, tzinfo=datetime.timezone.utc), 'symbols': ['GNS']}
{'headline': 'Dow Dips Over 300 Points But Records Weekly Gain: Greed Index Remains In &#39;Fear&#39; Zone', 'url': 'https://www.benzinga.com/news/earnings/24/12/42717902/dow-dips-over-300-points-but-records-weekly-gain-greed-index-remains-in-fear-zone', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 8, 28, 9, tzinfo=datetime.timezone.utc), 'symbols': ['NVDA', 'TSLA']}
{'headline': 'MSC Industrial Direct Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street&#39;s Most Accurate Analysts', 'url': 'https://www.benzinga.com/24/12/42717925/msc-industrial-direct-gears-up-for-q1-print-here-are-the-recent-forecast-changes-from-wall-streets-most-accurate-analysts', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 8, 30, 43, tzinfo=datetime.timezone.utc), 'symbols': ['MSM']}
{'headline': 'Reported Friday, Citius Pharmaceuticals FY24 EPS $(5.97) Down From $(5.57) YoY; Cash $3.3M', 'url': 'https://www.benzinga.com/news/earnings/24/12/42717934/reported-friday-citius-pharmaceuticals-fy24-eps-5-97-down-from-5-57-yoy-cash-3-3m', 'summary': 'Net loss was\xa0$39.4 million, or\xa0($5.97)\xa0per share for the year ended\xa0September 30, 2024, compared to a net loss of\xa0$32.5 million, or\xa0($5.57)\xa0per share for the year ended\xa0September', 'created date': datetime.datetime(2024, 12, 30, 8, 31, 22, tzinfo=datetime.timezone.utc), 'symbols': ['CTXR']}
{'headline': 'Reported Friday, FLANIGAN&#39;S ENTERPRISES FY24 EPS $1.81 Down From $2.15 YoY, Revenue $188.32M Up From $174.396M YoY', 'url': 'https://www.benzinga.com/news/earnings/24/12/42717964/reported-friday-flanigans-enterprises-fy24-eps-1-81-down-from-2-15-yoy-revenue-188-32m-up-from-174-', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 8, 38, 22, tzinfo=datetime.timezone.utc), 'symbols': ['BDL']}
{'headline': 'Tesla&#39;s Referral Benefits In North America To Reduce Starting 2025: Here&#39;s What You Should Know', 'url': 'https://www.benzinga.com/24/12/42717968/teslas-referral-benefits-to-reduce-starting-2025', 'summary': 'EV giant Tesla Inc said on Saturday that the company will reduce benefits as part of its referral program starting next year.', 'created date': datetime.datetime(2024, 12, 30, 8, 38, 53, tzinfo=datetime.timezone.utc), 'symbols': ['TSLA']}
{'headline': 'Reported Friday, Citius Oncology FY 2024 GAAP EPS $(0.31) Misses $(0.29) Estimate', 'url': 'https://www.benzinga.com/news/earnings/24/12/42717992/reported-friday-citius-oncology-fy-2024-gaap-eps-0-31-misses-0-29-estimate', 'summary': 'Citius Oncology (NASDAQ:CTOR) reported quarterly losses of $(0.31) per share which missed the analyst consensus estimate of $(0.29) by 6.9 percent. This is a 63.16 percent decrease over losses of $(0.19) per share from', 'created date': datetime.datetime(2024, 12, 30, 8, 40, 43, tzinfo=datetime.timezone.utc), 'symbols': ['CTOR']}
{'headline': 'Reported Friday, Willow Lane Acquisition Corp. Announces Separate Trading For Class A Shares And Warrants Starting December 30', 'url': 'https://www.benzinga.com/news/24/12/42717998/reported-friday-willow-lane-acquisition-corp-announces-separate-trading-for-class-a-shares-and-warra', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 8, 42, 43, tzinfo=datetime.timezone.utc), 'symbols': ['WLACU']}
{'headline': 'Days After Key Nvidia Supplier Warned Of AI Spending Slowdown, Another NVDA Partner Considers Accelerating Expansion To Meet Growing Demand', 'url': 'https://www.benzinga.com/tech/24/12/42718022/days-after-key-nvidia-supplier-warned-of-ai-spending-slowdown-another-nvda-partner-considers-accelerating-expansion-to-meet-growing-demand', 'summary': 'Nevertheless, Kawashima noted that even this planned capacity might fall short, prompting discussions on when to activate the remaining 50% capacity.', 'created date': datetime.datetime(2024, 12, 30, 8, 55, 56, tzinfo=datetime.timezone.utc), 'symbols': ['AMD', 'AVGO', 'INTC', 'NVDA', 'SSNLF', 'TSM']}
{'headline': 'Northland Capital Markets Maintains Outperform on Applied Optoelectronics, Lowers Price Target to $18', 'url': 'https://www.benzinga.com/news/24/12/42718179/northland-capital-markets-maintains-outperform-on-applied-optoelectronics-lowers-price-target-to-18', 'summary': 'Northland Capital Markets  analyst Tim Savageaux   maintains Applied Optoelectronics (NASDAQ:AAOI) with a Outperform and lowers the price target from $20 to $18.', 'created date': datetime.datetime(2024, 12, 30, 9, 25, 52, tzinfo=datetime.timezone.utc), 'symbols': ['AAOI']}
{'headline': 'Why Vincerx Pharma Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket', 'url': 'https://www.benzinga.com/24/12/42718376/why-vincerx-pharma-shares-are-trading-higher-by-around-64-here-are-20-stocks-moving-premarket', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 9, 56, 34, tzinfo=datetime.timezone.utc), 'symbols': ['AERT', 'AILE', 'CTM', 'CTXR', 'CVM', 'HONE', 'HSON', 'INTZ', 'KORE', 'LITM', 'NATR', 'PDYN', 'REKR', 'SII', 'SLDP', 'STI', 'TBN', 'VINC', 'WATT', 'WNW']}
{'headline': 'Aurora Mobile Approves $5M Share Repurchase Program Starting January 2025', 'url': 'https://www.benzinga.com/news/24/12/42718523/aurora-mobile-approves-5m-share-repurchase-program-starting-january-2025', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 10, 5, 21, tzinfo=datetime.timezone.utc), 'symbols': ['JG']}
{'headline': 'Boeing Shares Fall Over 4% In Monday Premarket As Airplane Maker Faces Scrutiny After Deadliest 737-800 Crash In South Korea', 'url': 'https://www.benzinga.com/markets/equities/24/12/42718607/boeing-shares-fall-over-4-in-monday-premarket-as-airplane-maker-faces-scrutiny-after-deadliest-737-800-crash-in-south-korea', 'summary': 'This catastrophe resulted in the loss of 179 lives', 'created date': datetime.datetime(2024, 12, 30, 10, 20, 45, tzinfo=datetime.timezone.utc), 'symbols': ['BA']}
{'headline': 'Reported Earlier, Novartis Reports Topline Results From Phase III STEER Study; Study Met Its Primary Endpoint', 'url': 'https://www.benzinga.com/news/24/12/42718629/reported-earlier-novartis-reports-topline-results-from-phase-iii-steer-study-study-met-its-primary-e', 'summary': 'This pivotal study assessed the efficacy and safety of investigational intrathecal onasemnogene abeparvovec (OAV101 IT) in treatment-naïve patients with spinal muscular atrophy (SMA) Type 2, aged two to less than 18', 'created date': datetime.datetime(2024, 12, 30, 10, 23, 55, tzinfo=datetime.timezone.utc), 'symbols': ['NVS']}
{'headline': 'Raymond James Upgrades American Airlines Gr to Outperform, Announces $24 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42718755/raymond-james-upgrades-american-airlines-gr-to-outperform-announces-24-price-target', 'summary': 'Raymond James  analyst Savanthi Syth   upgrades American Airlines Gr (NASDAQ:AAL) from Market Perform to Outperform and announces $24 price target.', 'created date': datetime.datetime(2024, 12, 30, 10, 30, 44, tzinfo=datetime.timezone.utc), 'symbols': ['AAL']}
{'headline': 'Emeren Signs 7-Year Power Purchase Agreement For 15 MWp Solar Farm In Poland', 'url': 'https://www.benzinga.com/news/24/12/42718983/emeren-signs-7-year-power-purchase-agreement-for-15-mwp-solar-farm-in-poland', 'summary': 'The solar farm, located in Poland&#39;s southwest Silesia region, will supply clean energy under a pay-as-produced agreement to the Polish subsidiary of a multinational consumer goods business.', 'created date': datetime.datetime(2024, 12, 30, 11, 1, 33, tzinfo=datetime.timezone.utc), 'symbols': ['SOL']}
{'headline': 'Stagwell To Acquires Create. Group To Expand Digital Marketing Reach, Financial Terms Undisclosed', 'url': 'https://www.benzinga.com/m-a/24/12/42719013/stagwell-to-acquires-create-group-to-expand-digital-marketing-reach-financial-terms-undisclosed', 'summary': '\xa0Stagwell\xa0(NASDAQ: STGW), the challenger network built to ', 'created date': datetime.datetime(2024, 12, 30, 11, 2, 50, tzinfo=datetime.timezone.utc), 'symbols': ['STGW']}
{'headline': 'Stagwell To Acquire Create. Group To Expand Digital Marketing Reach, Financial Terms Undisclosed', 'url': 'https://www.benzinga.com/m-a/24/12/42719013/stagwell-to-acquires-create-group-to-expand-digital-marketing-reach-financial-terms-undisclosed', 'summary': '\xa0Stagwell\xa0(NASDAQ: STGW), the challenger network built to ', 'created date': datetime.datetime(2024, 12, 30, 11, 2, 50, tzinfo=datetime.timezone.utc), 'symbols': ['STGW']}
{'headline': 'DA Davidson Maintains Buy on Procter &amp; Gamble, Maintains $209 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42719046/da-davidson-maintains-buy-on-procter-gamble-maintains-209-price-target', 'summary': 'DA Davidson  analyst Linda Bolton Weiser   maintains Procter &amp; Gamble (NYSE:PG) with a Buy and maintains $209 price target.', 'created date': datetime.datetime(2024, 12, 30, 11, 6, 47, tzinfo=datetime.timezone.utc), 'symbols': ['PG']}
{'headline': 'US Stock Futures Slip After Friday&#39;s Fall: &#39;Santa Rally&#39; In Doubt? Analyst Calls It A Bit Of Profit-Taking', 'url': 'https://www.benzinga.com/general/market-summary/24/12/42719119/us-stock-futures-slip-after-fridays-fall-santa-rally-in-doubt-analyst-calls-it-a-bit-of-profit-taking', 'summary': 'U.S. stock futures declined on Monday after ending lower on Friday. All four index futures slipped in trade.', 'created date': datetime.datetime(2024, 12, 30, 11, 15, 2, tzinfo=datetime.timezone.utc), 'symbols': ['AMPG', 'CCTG', 'CTXR', 'CVM', 'GNS', 'INTZ', 'NVDA', 'QQQ', 'SPY', 'TSLA']}
{'headline': 'On December 27, 2024, Amplitech Received Notice From Nasdaq On Regaining Compliance With Minimum Bid Price Requirement - Filing', 'url': 'https://www.benzinga.com/news/24/12/42719199/on-december-27-2024-amplitech-received-notice-from-nasdaq-on-regaining-compliance-with-minimum-bid-p', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 11, 19, 2, tzinfo=datetime.timezone.utc), 'symbols': ['AMPG']}
{'headline': 'Elon Musk&#39;s Starlink To Bring Space-Based Mobile Connectivity To Ukraine', 'url': 'https://www.benzinga.com/tech/24/12/42719245/elon-musks-starlink-to-bring-space-based-mobile-connectivity-to-ukraine', 'summary': 'Kyivstar has signed an agreement with Starlink to offer satellite connectivity.', 'created date': datetime.datetime(2024, 12, 30, 11, 24, 58, tzinfo=datetime.timezone.utc), 'symbols': ['ARKVX', 'DXYZ', 'TMUS']}
{'headline': 'Polyrizon Reports Publication Of A National Phase Patent Application By US Patent And Trademark Office', 'url': 'https://www.benzinga.com/news/24/12/42719258/polyrizon-reports-publication-of-a-national-phase-patent-application-by-us-patent-and-trademark-offi', 'summary': 'The patent application encompasses key aspects of Polyrizon&#39;s two core platform technologies: Capture and Contain, a nasal blocker technology, and Trap and Target, designed for advanced nasal drug delivery.\xa0', 'created date': datetime.datetime(2024, 12, 30, 11, 26, 25, tzinfo=datetime.timezone.utc), 'symbols': ['PLRZ']}
{'headline': 'AEye Updated Maximum Placement Shares To $5.23M Under At-Market Sales Agreement With A.G.P./Alliance Global Partners', 'url': 'https://www.benzinga.com/news/24/12/42719283/aeye-updated-maximum-placement-shares-to-5-23m-under-at-market-sales-agreement-with-a-g-p-alliance-g', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 11, 27, 15, tzinfo=datetime.timezone.utc), 'symbols': ['LIDR']}
{'headline': 'Halozyme and Bristol Myers Squibb Secure FDA Nod for Opdivo Qvantig', 'url': 'https://www.benzinga.com/government/24/12/42719422/halozyme-and-bristol-myers-squibb-secure-fda-nod-for-opdivo-qvantig', 'summary': 'Halozyme Therapeutics, Inc. (NASDAQ:HALO) (Halozyme) today announced that Bristol Myers Squibb received U.S. Food and Drug Administration (FDA) approval for Opdivo Qvantig™ (nivolumab and hyaluronidase-nvhy)', 'created date': datetime.datetime(2024, 12, 30, 11, 34, 12, tzinfo=datetime.timezone.utc), 'symbols': ['BMY', 'HALO']}
{'headline': 'Why Is Faraday Future Intelligent Electric Stock Trading Higher Today?', 'url': 'https://www.benzinga.com/24/12/42719434/why-is-faraday-future-intelligent-electric-trading-higher-on-premarket-on-monday', 'summary': 'Entrepreneur Luke Hans will receive first FF 91 2.0 Futurist Alliance EV from Faraday Future Intelligent Electric during ceremony with executives.', 'created date': datetime.datetime(2024, 12, 30, 11, 39, 52, tzinfo=datetime.timezone.utc), 'symbols': ['FFIE']}
{'headline': 'HC Wainwright &amp; Co. Maintains Buy on BigBear.ai Hldgs, Raises Price Target to $7', 'url': 'https://www.benzinga.com/news/24/12/42719455/hc-wainwright-co-maintains-buy-on-bigbear-ai-hldgs-raises-price-target-to-7', 'summary': 'HC Wainwright &amp; Co.  analyst Scott Buck   maintains BigBear.ai Hldgs (NYSE:BBAI) with a Buy and raises the price target from $3 to $7.', 'created date': datetime.datetime(2024, 12, 30, 11, 43, 19, tzinfo=datetime.timezone.utc), 'symbols': ['BBAI']}
{'headline': 'HC Wainwright &amp; Co. Initiates Coverage On Artiva Biotherapeutics with Buy Rating, Announces Price Target of $20', 'url': 'https://www.benzinga.com/news/24/12/42719517/hc-wainwright-co-initiates-coverage-on-artiva-biotherapeutics-with-buy-rating-announces-price-target', 'summary': 'HC Wainwright &amp; Co.  analyst Edward White   initiates coverage on Artiva Biotherapeutics (NASDAQ:ARTV) with a Buy rating and announces Price Target of $20.', 'created date': datetime.datetime(2024, 12, 30, 11, 46, 23, tzinfo=datetime.timezone.utc), 'symbols': ['ARTV']}
{'headline': 'HC Wainwright &amp; Co. Initiates Coverage On Nuvalent with Buy Rating, Announces Price Target of $110', 'url': 'https://www.benzinga.com/news/24/12/42719520/hc-wainwright-co-initiates-coverage-on-nuvalent-with-buy-rating-announces-price-target-of-110', 'summary': 'HC Wainwright &amp; Co.  analyst Swayampakula Ramakanth   initiates coverage on Nuvalent (NASDAQ:NUVL) with a Buy rating and announces Price Target of $110.', 'created date': datetime.datetime(2024, 12, 30, 11, 47, 58, tzinfo=datetime.timezone.utc), 'symbols': ['NUVL']}
{'headline': 'Geopolitical Tensions Trigger Natural Gas Futures 11% Jump, Asia And Europe Markets Mixed - Global Markets Today While Us Slept', 'url': 'https://www.benzinga.com/24/12/42719521/asia-and-europe-markets-mixed-natural-gas-jumps-10-oil-stable-on-demand-hopes-gold-slips-global-markets-today-while-us-slept', 'summary': 'U.S. markets closed lower on Friday due to rising Treasury yields and profit-taking, with all sectors declining. Asian markets also saw losses.', 'created date': datetime.datetime(2024, 12, 30, 11, 48, 4, tzinfo=datetime.timezone.utc), 'symbols': ['ADIV', 'AGOV', 'ASHR', 'BBEU', 'BOIL', 'CQQQ', 'DBC', 'EEM', 'EEMA', 'EWU', 'EZU', 'FLAX', 'FXA', 'FXB', 'FXC', 'FXE', 'FXI', 'GLD', 'GSG', 'GXC', 'IEMG', 'IEUR', 'IEV', 'KDIV', 'SPEM', 'SPY', 'UNG', 'USDU', 'USO', 'UUP', 'VGK', 'VWO']}
{'headline': 'Halozyme Says argenx&#39;s VYDURA With ENHANZE Granted Regulatory Approval In Japan For Chronic Inflammatory Demyelinating Polyneuropathy', 'url': 'https://www.benzinga.com/news/24/12/42719539/halozyme-says-argenxs-vydura-with-enhanze-granted-regulatory-approval-in-japan-for-chronic-inflammat', 'summary': '&#34;We are pleased that VYVDURA, with our innovative ENHANZE drug delivery technology, is now approved for two indications in Japan, enabling greater flexibility and optionality for generalized myasthenia gravis and CIDP', 'created date': datetime.datetime(2024, 12, 30, 11, 49, 13, tzinfo=datetime.timezone.utc), 'symbols': ['HALO']}
{'headline': 'HC Wainwright &amp; Co. Reiterates Buy on Halozyme Therapeutics, Maintains $68 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42719547/hc-wainwright-co-reiterates-buy-on-halozyme-therapeutics-maintains-68-price-target', 'summary': 'HC Wainwright &amp; Co.  analyst Mitchell Kapoor   reiterates Halozyme Therapeutics (NASDAQ:HALO) with a Buy and maintains $68 price target.', 'created date': datetime.datetime(2024, 12, 30, 11, 52, tzinfo=datetime.timezone.utc), 'symbols': ['HALO']}
{'headline': 'Jeffs&#39; Brands Says Drone Safety Systems Now Available On Amazon US', 'url': 'https://www.benzinga.com/news/24/12/42719548/jeffs-brands-says-drone-safety-systems-now-available-on-amazon-us', 'summary': 'Further to its announcement on December 5, 2024 regarding the entry into an agreement\xa0granting it the exclusive worldwide right to distribute certain advanced drone safety systems developed by a leading drone', 'created date': datetime.datetime(2024, 12, 30, 11, 52, 5, tzinfo=datetime.timezone.utc), 'symbols': ['JFBR']}
{'headline': 'HC Wainwright &amp; Co. Initiates Coverage On Arcutis Biotherapeutics with Buy Rating, Announces Price Target of $19', 'url': 'https://www.benzinga.com/news/24/12/42719555/hc-wainwright-co-initiates-coverage-on-arcutis-biotherapeutics-with-buy-rating-announces-price-targe', 'summary': 'HC Wainwright &amp; Co.  analyst Douglas Tsao   initiates coverage on Arcutis Biotherapeutics (NASDAQ:ARQT) with a Buy rating and announces Price Target of $19.', 'created date': datetime.datetime(2024, 12, 30, 11, 54, 46, tzinfo=datetime.timezone.utc), 'symbols': ['ARQT']}
{'headline': 'Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending', 'url': 'https://www.benzinga.com/24/12/42719580/trading-halt-halted-at-6-55-00-a-m-et-trading-halt-halt-news-pending', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 11, 55, 3, tzinfo=datetime.timezone.utc), 'symbols': ['MRNS']}
{'headline': 'Trading Halt: Halted at 6:55:00 a.m. ET - Trading Halt: Halt News Pending', 'url': 'https://www.benzinga.com/24/12/42719581/trading-halt-halted-at-6-55-00-a-m-et-trading-halt-halt-news-pending', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 11, 55, 3, tzinfo=datetime.timezone.utc), 'symbols': ['MHLD']}
{'headline': 'US Stock Futures Slip After Friday&#39;s Fall: &#39;Santa Rally&#39; In Doubt? Analyst Calls It A Bit Of Profit-Taking', 'url': 'https://www.benzinga.com/general/market-summary/24/12/42719119/us-stock-futures-slip-after-fridays-fall-santa-rally-in-doubt-analyst-calls-it-a-bit-of-profit-taking', 'summary': 'U.S. stock futures declined on Monday after ending lower on Friday. All four index futures slipped in trade.', 'created date': datetime.datetime(2024, 12, 30, 11, 14, 54, tzinfo=datetime.timezone.utc), 'symbols': ['AMPG', 'CCTG', 'CTXR', 'CVM', 'GNS', 'INTZ', 'NVDA', 'QQQ', 'SPY', 'TSLA']}
{'headline': 'HC Wainwright &amp; Co. Initiates Coverage On Emergent BioSolutions with Buy Rating, Announces Price Target of $15', 'url': 'https://www.benzinga.com/news/24/12/42719694/hc-wainwright-co-initiates-coverage-on-emergent-biosolutions-with-buy-rating-announces-price-target', 'summary': 'HC Wainwright &amp; Co.  analyst Raghuram Selvaraju   initiates coverage on Emergent BioSolutions (NYSE:EBS) with a Buy rating and announces Price Target of $15.', 'created date': datetime.datetime(2024, 12, 30, 11, 57, 34, tzinfo=datetime.timezone.utc), 'symbols': ['EBS']}
{'headline': 'Natural Gas Futures Rise 11% On Report Ukraine Declines To Renew Russia Gas Transit Deal As Year-End Expiration Looms', 'url': 'https://www.benzinga.com/news/24/12/42719695/natural-gas-futures-rise-11-on-report-ukraine-declines-to-renew-russia-gas-transit-deal-as-year-end', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 11, 58, 53, tzinfo=datetime.timezone.utc), 'symbols': ['SPY', 'UNG']}
{'headline': 'Deep Dive Into BigBear.ai Hldgs Stock: Analyst Perspectives (4 Ratings)', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42719733/deep-dive-into-bigbear-ai-hldgs-stock-analyst-perspectives-4-ratings', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 12, 0, 13, tzinfo=datetime.timezone.utc), 'symbols': ['BBAI']}
{'headline': 'Bitcoin Could Surge Past $250,000, Says Tom Lee Citing BTC Halving Cycles And US Government Adoption', 'url': 'https://www.benzinga.com/markets/cryptocurrency/24/12/42719735/bitcoin-could-surge-past-250000-says-tom-lee-citing-btc-halving-cycles-and-us-government-adoption', 'summary': 'Fundstrat‘s head of research Tom Lee reiterates his forecast that Bitcoin (CRYPTO: BTC) could surge beyond $250,000 wi', 'created date': datetime.datetime(2024, 12, 30, 12, 0, 20, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD', 'MSTR']}
{'headline': 'Chimerix Seeks FDA Approval for New Drug Targeting Deadly Brain Cancer', 'url': 'https://www.benzinga.com/government/24/12/42719763/chimerix-seeks-fda-approval-for-new-drug-targeting-deadly-brain-cancer', 'summary': 'Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today confirms that the Company has', 'created date': datetime.datetime(2024, 12, 30, 12, 1, 28, tzinfo=datetime.timezone.utc), 'symbols': ['CMRX']}
{'headline': 'HC Wainwright &amp; Co. Initiates Coverage On NewAmsterdam Pharma with Buy Rating, Announces Price Target of $48', 'url': 'https://www.benzinga.com/news/24/12/42719771/hc-wainwright-co-initiates-coverage-on-newamsterdam-pharma-with-buy-rating-announces-price-target-of', 'summary': 'HC Wainwright &amp; Co.  analyst Ed Arce   initiates coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with a Buy rating and announces Price Target of $48.', 'created date': datetime.datetime(2024, 12, 30, 12, 3, 10, tzinfo=datetime.timezone.utc), 'symbols': ['NAMS']}
{'headline': 'Immedica Pharma to Acquire Marinus Pharmaceuticals in Strategic Merger For $0.55/Share Implying An Enterprise Value Of $151M', 'url': 'https://www.benzinga.com/m-a/24/12/42719781/immedica-pharma-to-acquire-marinus-pharmaceuticals-in-strategic-merger-for-0-55share-implying-an-ent', 'summary': 'Immedica Pharma AB (Immedica), a leading global rare disease company, and Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS), a pharmaceutical company committed to improving the lives of patients with seizure disorders, today', 'created date': datetime.datetime(2024, 12, 30, 12, 4, tzinfo=datetime.timezone.utc), 'symbols': ['MRNS']}
{'headline': 'Wabtec Acquires Bloom Engineering, Inc., A Provider In Industrial Heating Applications, For $69M In Cash', 'url': 'https://www.benzinga.com/m-a/24/12/42719783/wabtec-acquires-bloom-engineering-inc-a-provider-in-industrial-heating-applications-for-69m-in-cash', 'summary': 'This acquisition strengthens Wabtec&#39;s portfolio of heat transfer and energy solutions, integrating Bloom Engineering&#39;s advanced technologies in burners, combustion systems, and overall services for industrial and process', 'created date': datetime.datetime(2024, 12, 30, 12, 4, 40, tzinfo=datetime.timezone.utc), 'symbols': ['WAB']}
{'headline': 'Tesla Bull Urges Investors To Do Their Own Research: &#39;...CEOs Are Paid To Be Optimistic...&#39;', 'url': 'https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42719784/tesla-bull-urges-investors-to-do-their-own-research-ceos-are-paid-to-be-optimistic', 'summary': 'Gary Black of The Future Fund urges investors to do their own research rather than relying on company management.', 'created date': datetime.datetime(2024, 12, 30, 12, 4, 47, tzinfo=datetime.timezone.utc), 'symbols': ['TSLA']}
{'headline': 'Four Commodity Stocks To Watch In 2025', 'url': 'https://www.benzinga.com/24/12/42719808/four-commodity-stocks-to-watch-in-2025', 'summary': 'Positive trends for commodities likely to continue in 2025. Junior companies exploring safe jurisdictions include Volt Lithium, Northern Superior, Sierra Madre Gold and Silver, and Friedman Industries.', 'created date': datetime.datetime(2024, 12, 30, 12, 5, 24, tzinfo=datetime.timezone.utc), 'symbols': ['AEM', 'FRD', 'NSUPF', 'ONGRF', 'SMDRF', 'VLTLF']}
{'headline': 'Gilat Satellite Secures $18M in Orders for In-Flight Connectivity Solutions', 'url': 'https://www.benzinga.com/news/24/12/42719809/gilat-satellite-secures-18m-in-orders-for-in-flight-connectivity-solutions', 'summary': 'Gilat Satellite Networks Ltd. (NASDAQ, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that the Company has secured over $18 million in orders for IFC', 'created date': datetime.datetime(2024, 12, 30, 12, 5, 40, tzinfo=datetime.timezone.utc), 'symbols': ['GILT']}
{'headline': 'Can-Fite To Present Data At The 2025 Asco Gastrointestinal Cancers Symposium; Enrolls Patients For Its Pivotal Phase III dvanced Liver Cancer Study', 'url': 'https://www.benzinga.com/news/24/12/42719821/can-fite-to-present-data-at-the-2025-asco-gastrointestinal-cancers-symposium-enrolls-patients-for-it', 'summary': 'Currently, Namodenoson is being evaluated in a pivotal Phase 3 multinational registrational trial for the treatment of advanced liver cancer (Hepatocellular Carcinoma; HCC).', 'created date': datetime.datetime(2024, 12, 30, 12, 6, 32, tzinfo=datetime.timezone.utc), 'symbols': ['CANF']}
{'headline': 'Maiden and Kestrel Announce $167.5M Merger to Create Specialty Program Group', 'url': 'https://www.benzinga.com/m-a/24/12/42719823/maiden-and-kestrel-announce-167-5m-merger-to-create-specialty-program-group', 'summary': 'Maiden Holdings, Ltd. (NASDAQ:MHLD) (&#34;Maiden&#34; or the &#34;Company&#34;) and Kestrel Group LLC (&#34;Kestrel&#34;) today announced that they have entered into a combination agreement to combine and form a new, publicly listed specialty', 'created date': datetime.datetime(2024, 12, 30, 12, 7, 12, tzinfo=datetime.timezone.utc), 'symbols': ['MHLD']}
{'headline': 'Precigen Seeks FDA Priority Review for Gene Therapy Targeting Rare Respiratory Disease', 'url': 'https://www.benzinga.com/government/24/12/42719841/precigen-seeks-fda-priority-review-for-gene-therapy-targeting-rare-respiratory-disease', 'summary': '\xa0Precigen, Inc.\xa0(NASDAQ:PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced the completion of the rolling', 'created date': datetime.datetime(2024, 12, 30, 12, 8, 24, tzinfo=datetime.timezone.utc), 'symbols': ['PGEN']}
{'headline': 'Johnson &amp; Johnson Says European Commission Has Approved RYBREVANT (Amivantamab) In Combination With LAZCLUZE (Lazertinib) For  First-line Treatment Of Patients With EGFR-mutated Advanced Non-Small Cell Lung Cancer', 'url': 'https://www.benzinga.com/news/24/12/42719853/johnson-johnson-says-european-commission-has-approved-rybrevant-amivantamab-in-combination-with-lazc', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 12, 9, 26, tzinfo=datetime.timezone.utc), 'symbols': ['JNJ']}
{'headline': 'Axsome Completes Phase 3 Trials for AXS-05 in Alzheimer&#39;s Agitation, Plans FDA Submission for Alzheimer&#39;s Agitation Drug in 2025', 'url': 'https://www.benzinga.com/government/24/12/42719865/axsome-completes-phase-3-trials-for-axs-05-in-alzheimers-agitation-plans-fda-submission-for-alzheime', 'summary': 'Axsome Therapeutics, Inc. (NASDAQ:AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced the successful completion of', 'created date': datetime.datetime(2024, 12, 30, 12, 10, 44, tzinfo=datetime.timezone.utc), 'symbols': ['AXSM']}
{'headline': 'Chimerix Confirms That It Has Submitted New Drug Application With FDA Seeking Accelerated Approval For Dordaviprone As Treatment For Patients With Recurrent H3 K27M-mutant Diffuse Glioma In US', 'url': 'https://www.benzinga.com/news/24/12/42719870/chimerix-confirms-that-it-has-submitted-new-drug-application-with-fda-seeking-accelerated-approval-f', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 12, 10, 57, tzinfo=datetime.timezone.utc), 'symbols': ['CMRX']}
{'headline': 'HC Wainwright &amp; Co. Initiates Coverage On MetaVia with Buy Rating, Announces Price Target of $12', 'url': 'https://www.benzinga.com/news/24/12/42719876/hc-wainwright-co-initiates-coverage-on-metavia-with-buy-rating-announces-price-target-of-12', 'summary': 'HC Wainwright &amp; Co.  analyst Ed Arce   initiates coverage on MetaVia (NASDAQ:MTVA) with a Buy rating and announces Price Target of $12.', 'created date': datetime.datetime(2024, 12, 30, 12, 12, 4, tzinfo=datetime.timezone.utc), 'symbols': ['MTVA']}
{'headline': 'Brazil Potash Secures Key Water Permits for Massive Fertilizer Project in Amazon', 'url': 'https://www.benzinga.com/government/24/12/42719879/brazil-potash-secures-key-water-permits-for-massive-fertilizer-project-in-amazon', 'summary': 'Brazil Potash Corp. (&#34;Brazil Potash&#34; or the &#34;Company&#34;) (NYSE:GRO), a company developing and constructing the largest potash fertilizer project in Brazil, the Autazes Potash Project (the &#34;Project&#34;), announces that its', 'created date': datetime.datetime(2024, 12, 30, 12, 13, 21, tzinfo=datetime.timezone.utc), 'symbols': ['GRO']}
{'headline': 'Top 3 Consumer Stocks That May Explode In December', 'url': 'https://www.benzinga.com/24/12/42719894/top-3-consumer-stocks-that-may-explode-in-december', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 12, 14, 43, tzinfo=datetime.timezone.utc), 'symbols': ['FLL', 'GES', 'RGR']}
{'headline': 'D. Boral Capital Upgrades Citius Pharma to Buy, Announces $9 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42719964/d-boral-capital-upgrades-citius-pharma-to-buy-announces-9-price-target', 'summary': 'D. Boral Capital  analyst Jason Kolbert   upgrades Citius Pharma (NASDAQ:CTXR) from Hold to Buy and announces $9 price target.', 'created date': datetime.datetime(2024, 12, 30, 12, 17, 46, tzinfo=datetime.timezone.utc), 'symbols': ['CTXR']}
{'headline': 'D. Boral Capital Maintains Buy on New Horizon Aircraft, Maintains $2 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42719975/d-boral-capital-maintains-buy-on-new-horizon-aircraft-maintains-2-price-target', 'summary': 'D. Boral Capital  analyst Jesse Sobelson   maintains New Horizon Aircraft (NASDAQ:HOVR) with a Buy and maintains $2 price target.', 'created date': datetime.datetime(2024, 12, 30, 12, 22, 22, tzinfo=datetime.timezone.utc), 'symbols': ['HOVR']}
{'headline': 'Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times', 'url': 'https://www.benzinga.com/24/12/42720019/trading-halt-halt-status-updated-at-7-25-00-am-et-quotation-resumption-news-and-resumption-times', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 12, 25, 4, tzinfo=datetime.timezone.utc), 'symbols': ['MHLD']}
{'headline': 'Market-Moving News for December 30th', 'url': 'https://www.benzinga.com/trading-ideas/movers/24/12/42720148/market-moving-news-for-december-30th', 'summary': 'CCTG: 83% | CCSC Technology International Holdings shares are trading higher after the company reported financial results for the first six months of FY25.\xa0PLRZ: 93% | Polyrizon Reports Publication Of A', 'created date': datetime.datetime(2024, 12, 30, 12, 27, 49, tzinfo=datetime.timezone.utc), 'symbols': ['AMPG', 'CCTG', 'PLRZ']}
{'headline': 'EXCLUSIVE: Janover Tells Benzinga Co. Announces Bitcoin Adoption, Says Co. Will Begin Accepting Bitcoin As Payment For Products And Consider For Treasury', 'url': 'https://www.benzinga.com/news/24/12/42720169/exclusive-janover-tells-benzinga-co-announces-bitcoin-adoption-says-co-will-begin-accepting-bitcoin', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 12, 30, 16, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD', 'JNVR']}
{'headline': 'V2X Secures $170M Drug Enforcement Administration Aircraft Support Contract', 'url': 'https://www.benzinga.com/government/24/12/42720171/v2x-secures-170m-drug-enforcement-administration-aircraft-support-contract', 'summary': 'V2X, Inc. (NYSE:\xa0VVX) is proud to announce the award of a $170 million contract to continue its critical support of the Drug Enforcement Administration&#39;s (DEA) fleet of over 100 aircraft. This award reinforces V2X&#39;s', 'created date': datetime.datetime(2024, 12, 30, 12, 30, 17, tzinfo=datetime.timezone.utc), 'symbols': ['VVX']}
{'headline': 'EXCLUSIVE: Janover To Accept Bitcoin Payments And Consider Crypto For Treasury Allocation', 'url': 'https://www.benzinga.com/markets/cryptocurrency/24/12/42720170/exclusive-janover-to-accept-bitcoin-payments-and-consider-crypto-for-treasury-allocation', 'summary': 'On Monday, Janover Inc (NASDAQ:JNVR) announced it will begin accepting payments in Bitcoin (CRYPTO: BTC), Ethereum (CRYPTO: ', 'created date': datetime.datetime(2024, 12, 30, 12, 30, 18, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD', 'ETHUSD', 'JNVR', 'MSTR', 'SOLUSD']}
{'headline': 'Will Trump Administration Sell Gold To Buy Bitcoin For Strategic Reserve In 2025? Analyst Says American Public Won&#39;t &#39;Tolerate&#39; That', 'url': 'https://www.benzinga.com/markets/cryptocurrency/24/12/42720168/will-trump-administration-sell-gold-to-buy-bitcoin-for-strategic-reserve-in-2025-analyst-says-american-public-wont-tolerate-that', 'summary': 'As President-elect Donald Trump prepares to take office in 2025, the cryptocurrency market hoped that a strategic Bitcoin (CRYPTO: BTC) reserve would take wings and eventually be implemented.', 'created date': datetime.datetime(2024, 12, 30, 12, 30, 25, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD']}
{'headline': 'Lichen China Announces $3.1M Registered Direct Offering Of 25M Shares At $0.125/Share', 'url': 'https://www.benzinga.com/news/24/12/42720204/lichen-china-announces-3-1m-registered-direct-offering-of-25m-shares-at-0-125share', 'summary': 'Lichen China Limited (NASDAQ:LICN)\xa0(&#34;Lichen China&#34; or the &#34;Company&#34;), a dedicated financial and taxation service provider in\xa0China today announced that it has entered into a definitive agreement with several', 'created date': datetime.datetime(2024, 12, 30, 12, 32, 51, tzinfo=datetime.timezone.utc), 'symbols': ['LICN']}
{'headline': 'NLS Pharmaceutics, Kadimastem Reort Filing Of F-4 Registration Statement With SEC Ahead Of Proposed Merger', 'url': 'https://www.benzinga.com/m-a/24/12/42720218/nls-pharmaceutics-kadimastem-reort-filing-of-f-4-registration-statement-with-sec-ahead-of-proposed-m', 'summary': 'The proposed Transaction will be affected through a reverse triangular structure in which Kadimastem will become a wholly owned subsidiary of NLS.\xa0In consideration,\xa0NLS will issue common shares to the', 'created date': datetime.datetime(2024, 12, 30, 12, 34, 15, tzinfo=datetime.timezone.utc), 'symbols': ['NLSP']}
{'headline': 'Amylyx and Gubra Join Forces for Peptide Drug Discovery Collaboration', 'url': 'https://www.benzinga.com/news/24/12/42720219/amylyx-and-gubra-join-forces-for-peptide-drug-discovery-collaboration', 'summary': 'Today, Gubra A/S (&#34;Company&#34;), a company specializing in pre-clinical contract research services and peptide-based drug discovery within metabolic and fibrotic diseases, announced a collaboration with Amylyx', 'created date': datetime.datetime(2024, 12, 30, 12, 34, 46, tzinfo=datetime.timezone.utc), 'symbols': ['AMLX']}
{'headline': 'AppTech Payments Reveals Departure Of Luke D&#39;angelo As CEO And Executive Director And  Appointment Of Thomas Derosa To Serve As Interim CEO - Filing', 'url': 'https://www.benzinga.com/news/24/12/42720259/apptech-payments-reveals-departure-of-luke-dangelo-as-ceo-and-executive-director-and-appointment-of', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 12, 38, 5, tzinfo=datetime.timezone.utc), 'symbols': ['APCX']}
{'headline': 'AppTech Payments Says Meilin Yu&#39;s Employment With And Service As CFO And Treasurer Was Terminated Without Cause', 'url': 'https://www.benzinga.com/news/24/12/42720277/apptech-payments-says-meilin-yus-employment-with-and-service-as-cfo-and-treasurer-was-terminated-wit', 'summary': 'The termination of Ms. Yu was not due to a disagreement with the Company on any matter relating to the Company&#39;s operations, policies, or practices.On December 24, 2024, the Company&#39;s Board of Directors appointed Felipe', 'created date': datetime.datetime(2024, 12, 30, 12, 40, 9, tzinfo=datetime.timezone.utc), 'symbols': ['APCX']}
{'headline': 'AppTech Payments Reveals Departure Of Luke D&#39;Angelo As CEO And Executive Director And  Appointment Of Thomas DeRosa To Serve As Interim CEO - Filing', 'url': 'https://www.benzinga.com/news/24/12/42720259/apptech-payments-reveals-departure-of-luke-dangelo-as-ceo-and-executive-director-and-appointment-of', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 12, 38, 5, tzinfo=datetime.timezone.utc), 'symbols': ['APCX']}
{'headline': 'Wall Street&#39;s Most Accurate Analysts Give Their Take On 3 Defensive Stocks With Over 4% Dividend Yields', 'url': 'https://www.benzinga.com/24/12/42720292/wall-streets-most-accurate-analysts-give-their-take-on-3-defensive-stocks-with-over-4-dividend-yields', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 12, 44, 42, tzinfo=datetime.timezone.utc), 'symbols': ['BGS', 'FLO', 'KHC']}
{'headline': 'This Analyst With 82% Accuracy Rate Sees Around 28% Upside In Apple - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts', 'url': 'https://www.benzinga.com/24/12/42720315/this-analyst-with-82-accuracy-rate-sees-around-28-upside-in-apple-here-are-5-stock-picks-for-last-week-from-wall-streets-most-accurate-analysts', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 12, 45, 15, tzinfo=datetime.timezone.utc), 'symbols': ['AAPL', 'DDOG', 'ENFN', 'GOOG', 'GOOGL', 'HBAN']}
{'headline': 'Baird Maintains Outperform on Polaris, Lowers Price Target to $72', 'url': 'https://www.benzinga.com/news/24/12/42720341/baird-maintains-outperform-on-polaris-lowers-price-target-to-72', 'summary': 'Baird  analyst Craig Kennison   maintains Polaris (NYSE:PII) with a Outperform and lowers the price target from $84 to $72.', 'created date': datetime.datetime(2024, 12, 30, 12, 49, 41, tzinfo=datetime.timezone.utc), 'symbols': ['PII']}
{'headline': 'Ethereum To Outperform Bitcoin In Q1 2025 For These 3 Reasons, Whale Trader Says', 'url': 'https://www.benzinga.com/markets/cryptocurrency/24/12/42720351/ethereum-to-outperform-bitcoin-in-q1-2025-for-these-3-reasons-whale-trader-says', 'summary': 'According to a prominent whale trader, Ethereum (CRYPTO: ETH) could be positioned for a successful first quarter in 2025. ', 'created date': datetime.datetime(2024, 12, 30, 12, 50, 57, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD', 'ETHUSD', 'SOLUSD']}
{'headline': 'This Nuvalent Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday', 'url': 'https://www.benzinga.com/24/12/42720371/this-nuvalent-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 12, 54, 59, tzinfo=datetime.timezone.utc), 'symbols': ['ARQT', 'ARTV', 'EBS', 'MTVA', 'NUVL']}
{'headline': 'Raymond James Maintains Outperform on Allegiant Travel, Raises Price Target to $110', 'url': 'https://www.benzinga.com/news/24/12/42720396/raymond-james-maintains-outperform-on-allegiant-travel-raises-price-target-to-110', 'summary': 'Raymond James  analyst Savanthi Syth   maintains Allegiant Travel (NASDAQ:ALGT) with a Outperform and raises the price target from $75 to $110.', 'created date': datetime.datetime(2024, 12, 30, 12, 56, 57, tzinfo=datetime.timezone.utc), 'symbols': ['ALGT']}
{'headline': 'Zebra Technologies Intends To Acquire Photoneo, A Developer And Manufacturer Of 3D Machine Vision Solutions; Financial Terms Not Disclosed', 'url': 'https://www.benzinga.com/m-a/24/12/42720552/zebra-technologies-intends-to-acquire-photoneo-a-developer-and-manufacturer-of-3d-machine-vision-sol', 'summary': 'This acquisition is accretive to Zebra&#39;s profitable growth profile while advancing the company&#39;s portfolio of machine vision solutions. Zebra expects to fund the purchase price with cash on hand. The transaction is', 'created date': datetime.datetime(2024, 12, 30, 12, 58, 58, tzinfo=datetime.timezone.utc), 'symbols': ['ZBRA']}
{'headline': 'P/E Ratio Insights for HDFC Bank', 'url': 'https://www.benzinga.com/insights/news/24/12/42720617/pe-ratio-insights-for-hdfc-bank', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 0, 14, tzinfo=datetime.timezone.utc), 'symbols': ['HDB']}
{'headline': 'Where NewAmsterdam Pharma Stands With Analysts', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42720620/where-newamsterdam-pharma-stands-with-analysts', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 0, 18, tzinfo=datetime.timezone.utc), 'symbols': ['NAMS']}
{'headline': 'What Analysts Are Saying About Polaris Stock', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42720637/what-analysts-are-saying-about-polaris-stock', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 0, 30, tzinfo=datetime.timezone.utc), 'symbols': ['PII']}
{'headline': 'Breaking Down Allegiant Travel: 10 Analysts Share Their Views', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42720641/breaking-down-allegiant-travel-10-analysts-share-their-views', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 0, 44, tzinfo=datetime.timezone.utc), 'symbols': ['ALGT']}
{'headline': 'Bit Digital Acquires Real Estate And Building For A Build-to-suit 5MW Tier-3 Data Center Expansion Project In Montreal, Canada; Purchases MTL2 Site For $23.3M', 'url': 'https://www.benzinga.com/m-a/24/12/42720682/bit-digital-acquires-real-estate-and-building-for-a-build-to-suit-5mw-tier-3-data-center-expansion-p', 'summary': 'This acquisition is part of Bit Digital&#39;s strategy to expand its HPC data center footprint to 32MW during 2025. This site also comprises part of Bit Digital&#39;s 288MW proprietary pipeline announced earlier this year.\xa0', 'created date': datetime.datetime(2024, 12, 30, 13, 3, 11, tzinfo=datetime.timezone.utc), 'symbols': ['BTBT']}
{'headline': 'Nano Labs Launches Bitcoin Subsidiary, Nano bit HK', 'url': 'https://www.benzinga.com/markets/cryptocurrency/24/12/42720684/nano-labs-launches-bitcoin-subsidiary-nano-bit-hk', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 3, 20, tzinfo=datetime.timezone.utc), 'symbols': ['NA']}
{'headline': 'Raymond James Maintains Outperform on SkyWest, Raises Price Target to $120', 'url': 'https://www.benzinga.com/news/24/12/42720685/raymond-james-maintains-outperform-on-skywest-raises-price-target-to-120', 'summary': 'Raymond James  analyst Savanthi Syth   maintains SkyWest (NASDAQ:SKYW) with a Outperform and raises the price target from $114 to $120.', 'created date': datetime.datetime(2024, 12, 30, 13, 3, 40, tzinfo=datetime.timezone.utc), 'symbols': ['SKYW']}
{'headline': 'Hesai Technology Says It Delivered More Than 100,000 Lidar Units During December', 'url': 'https://www.benzinga.com/news/24/12/42720688/hesai-technology-says-it-delivered-more-than-100-000-lidar-units-during-december', 'summary': 'Meanwhile, Hesai also announced a record number of lidar deliveries for the robotics market, surpassing 20,000 lidar units in December.In 2025, Hesai&#39;s planned annual capacity exceeds 2 million units , supported by the', 'created date': datetime.datetime(2024, 12, 30, 13, 4, 34, tzinfo=datetime.timezone.utc), 'symbols': ['HSAI']}
{'headline': 'Worksport Projects Exceeding 2024 Revenue Guidance Of $8M', 'url': 'https://www.benzinga.com/news/24/12/42720749/worksport-projects-exceeding-2024-revenue-guidance-of-8m', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 5, 7, tzinfo=datetime.timezone.utc), 'symbols': ['WKSP']}
{'headline': 'NRx Pharmaceuticals Files Initial Section of US New Drug Application To FDA For NRX-100 In Treatment Of Suicidal Depression', 'url': 'https://www.benzinga.com/news/24/12/42720750/nrx-pharmaceuticals-files-initial-section-of-us-new-drug-application-to-fda-for-nrx-100-in-treatment', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 6, 9, tzinfo=datetime.timezone.utc), 'symbols': ['NRXP']}
{'headline': 'Evaxion Biotech Plans To Change Ratio Of Its American Depositary Shares', 'url': 'https://www.benzinga.com/news/24/12/42720756/evaxion-biotech-plans-to-change-ratio-of-its-american-depositary-shares', 'summary': 'It plans to change the ratio of its American Depositary Shares to its ordinary shares, DKK 1 nominal value, from the current one (1) ADS representing ten (10) ordinary share to a new ADS ratio of one (1) ADS representing', 'created date': datetime.datetime(2024, 12, 30, 13, 6, 35, tzinfo=datetime.timezone.utc), 'symbols': ['EVAX']}
{'headline': 'Safe Pro Group Received Request From Ukraine&#39;s State Special Transport Service To Secure $5M For Purchase Of Up To 50 Safe Pro AI Powered Drone Demining Packages', 'url': 'https://www.benzinga.com/news/24/12/42720757/safe-pro-group-received-request-from-ukraines-state-special-transport-service-to-secure-5m-for-purch', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 7, 17, tzinfo=datetime.timezone.utc), 'symbols': ['SPAI']}
{'headline': 'Raymond James Maintains Outperform on Southwest Airlines, Raises Price Target to $40', 'url': 'https://www.benzinga.com/news/24/12/42720763/raymond-james-maintains-outperform-on-southwest-airlines-raises-price-target-to-40', 'summary': 'Raymond James  analyst Savanthi Syth   maintains Southwest Airlines (NYSE:LUV) with a Outperform and raises the price target from $36 to $40.', 'created date': datetime.datetime(2024, 12, 30, 13, 7, 40, tzinfo=datetime.timezone.utc), 'symbols': ['LUV']}
{'headline': 'Ryde Targets 1,200 Additional EVs by 2027 in Singapore', 'url': 'https://www.benzinga.com/news/24/12/42720771/ryde-targets-1-200-additional-evs-by-2027-in-singapore', 'summary': 'Ryde Group Ltd (NYSE:RYDE) (&#34;Ryde&#39;&#39; or the &#34;Company&#34;), a technology company with a leading platform for mobility and quick commerce in Singapore, is accelerating the green mobility revolution in Singapore with its', 'created date': datetime.datetime(2024, 12, 30, 13, 8, 23, tzinfo=datetime.timezone.utc), 'symbols': ['RYDE']}
{'headline': 'Traws Pharma Enters Agreements To Raise Up To $72.6M From Healthcare Institutional Investors To Advance Tivoxavir Marboxil Development', 'url': 'https://www.benzinga.com/news/24/12/42720772/traws-pharma-enters-agreements-to-raise-up-to-72-6m-from-healthcare-institutional-investors-to-advan', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 8, 36, tzinfo=datetime.timezone.utc), 'symbols': ['TRAW']}
{'headline': 'Shareholder Fund 1 Says Vera Bradley&#39;s Brand is Highly Valuable and That Value Is Not Reflected in Share Price; Says Pleased To Hear All Options Are On The Table To Maximize Shareholder Value', 'url': 'https://www.benzinga.com/news/24/12/42720774/shareholder-fund-1-says-vera-bradleys-brand-is-highly-valuable-and-that-value-is-not-reflected-in-sh', 'summary': 'Fund 1 Investments LLC beneficially owns 10.0% of Vera Bradley&#39;s outstanding shares.', 'created date': datetime.datetime(2024, 12, 30, 13, 9, 5, tzinfo=datetime.timezone.utc), 'symbols': ['VRA']}
{'headline': 'Genius Group increases Bitcoin Treasury by 50% to $30 million, reports 1,649% BTC Yield in Q4 2024', 'url': 'https://www.benzinga.com/markets/cryptocurrency/24/12/42720775/genius-group-increases-bitcoin-treasury-by-50-to-30-million-reports-1-649-btc-yield-in-q4-', 'summary': 'Genius Group Limited (NYSE:GNS) (&#34;Genius Group&#34; or the &#34;Company&#34;), a leading AI-powered, Bitcoin-first education group, today announced that it had increased its Bitcoin purchases for its Bitcoin Treasury by an', 'created date': datetime.datetime(2024, 12, 30, 13, 9, 22, tzinfo=datetime.timezone.utc), 'symbols': ['GNS']}
{'headline': 'Scam Alert: Squid Games Tokens &#39;Circulating In The Wind,&#39; Security Firm Advises Caution', 'url': 'https://www.benzinga.com/general/entertainment/24/12/42720781/scam-alert-squid-games-tokens-circulating-in-the-wind-security-firm-advises-caution', 'summary': 'The ghost of “Squid Games” scam tokens returned as the makers renewed the popular Netflix survival thriller series for a second season on Friday.\n\n\n\nWhat Happened: With the hype around the show reaching a fever peak, a handful of cryptocurrencies with dubious origins started to circulate in the market, preying on unsuspecting traders.', 'created date': datetime.datetime(2024, 12, 30, 13, 9, 47, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD', 'ETHUSD']}
{'headline': 'United States Antimony Corporation Enters Agreement For Supply Of Antimony Consisting Of 50 Wet Metric Tons Or Two Full Containers', 'url': 'https://www.benzinga.com/news/24/12/42720782/united-states-antimony-corporation-enters-agreement-for-supply-of-antimony-consisting-of-50-wet-metr', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 9, 55, tzinfo=datetime.timezone.utc), 'symbols': ['UAMY']}
{'headline': 'Rosenblatt Maintains Buy on Ribbon Comms, Maintains $5.5 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42720793/rosenblatt-maintains-buy-on-ribbon-comms-maintains-5-5-price-target', 'summary': 'Rosenblatt  analyst Mike Genovese   maintains Ribbon Comms (NASDAQ:RBBN) with a Buy and maintains $5.5 price target.', 'created date': datetime.datetime(2024, 12, 30, 13, 10, 5, tzinfo=datetime.timezone.utc), 'symbols': ['RBBN']}
{'headline': 'Leading And Lagging Sectors For December 30, 2024', 'url': 'https://www.benzinga.com/insights/sector-etfs/24/12/42720794/leading-and-lagging-sectors-for-december-30-2024', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 10, 6, tzinfo=datetime.timezone.utc), 'symbols': ['XLC', 'XLE', 'XLF', 'XLI', 'XLK', 'XLP', 'XLRE', 'XLU', 'XLV']}
{'headline': 'Embraer Reveals Firm Order For Six Light Attack And Advanced Trainer A-29 Super Tucanos Placed By An Undisclosed Customer', 'url': 'https://www.benzinga.com/news/24/12/42720795/embraer-reveals-firm-order-for-six-light-attack-and-advanced-trainer-a-29-super-tucanos-placed-by-an', 'summary': 'This order will be included in the 4Q24 backlog and deliveries are scheduled to take place in 2026.\xa0', 'created date': datetime.datetime(2024, 12, 30, 13, 10, 6, tzinfo=datetime.timezone.utc), 'symbols': ['ERJ']}
{'headline': 'Raymond James Maintains Outperform on United Airlines Holdings, Raises Price Target to $120', 'url': 'https://www.benzinga.com/news/24/12/42720821/raymond-james-maintains-outperform-on-united-airlines-holdings-raises-price-target-to-120', 'summary': 'Raymond James  analyst Savanthi Syth   maintains United Airlines Holdings (NASDAQ:UAL) with a Outperform and raises the price target from $90 to $120.', 'created date': datetime.datetime(2024, 12, 30, 13, 10, 20, tzinfo=datetime.timezone.utc), 'symbols': ['UAL']}
{'headline': 'IonQ Reveals Technological Breakthrough That Shows New Approach To Scalable Quantum Computing, Resulting From Collaboration With Oak Ridge National Laboratory', 'url': 'https://www.benzinga.com/news/24/12/42720851/ionq-reveals-technological-breakthrough-that-shows-new-approach-to-scalable-quantum-computing-result', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 11, 25, tzinfo=datetime.timezone.utc), 'symbols': ['IONQ']}
{'headline': 'NLS Pharmaceutics, Kadimastem Report Filing Of F-4 Registration Statement With SEC Ahead Of Proposed Merger', 'url': 'https://www.benzinga.com/m-a/24/12/42720218/nls-pharmaceutics-kadimastem-reort-filing-of-f-4-registration-statement-with-sec-ahead-of-proposed-m', 'summary': 'The proposed Transaction will be affected through a reverse triangular structure in which Kadimastem will become a wholly owned subsidiary of NLS.\xa0In consideration,\xa0NLS will issue common shares to theThe proposed Transaction will be affected through a reverse triangular structure in which Kadimastem will become a wholly owned subsidiary of NLS.\xa0', 'created date': datetime.datetime(2024, 12, 30, 12, 34, 15, tzinfo=datetime.timezone.utc), 'symbols': ['NLSP']}
{'headline': 'Foresight Signs Commercial Cooperation Agreement Up To $7M With KONEC To Distribute Technology And Products In South Korea', 'url': 'https://www.benzinga.com/news/24/12/42720853/foresight-signs-commercial-cooperation-agreement-up-to-7m-with-konec-to-distribute-technology-and-pr', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 12, 19, tzinfo=datetime.timezone.utc), 'symbols': ['FRSX']}
{'headline': 'Axsome Therapeutics, Tesla And Other Big Stocks Moving Lower In Monday&#39;s Pre-Market Session', 'url': 'https://www.benzinga.com/trading-ideas/movers/24/12/42720865/axsome-therapeutics-tesla-and-other-big-stocks-moving-lower-in-mondays-pre-market-session', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 13, 20, tzinfo=datetime.timezone.utc), 'symbols': ['ARQQ', 'AXSM', 'CRGX', 'ICG', 'IMKTA', 'LAES', 'MCFT', 'MD', 'MRC', 'PKST', 'TSLA']}
{'headline': 'Bond Vigilantes Send &#39;Loud Warning Message&#39; As Treasuries Climb To May Highs: Is The Santa Rally In &#39;Serious Doubt&#39;? Here&#39;s What Analysts Say', 'url': 'https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42720866/bond-vigilantes-send-loud-warning-message-as-treasuries-climb-to-may-highs-is-the-santa-rally-in-serious-doubt-heres-what-analysts-say', 'summary': 'The yield on the 10-year Treasury bond hit a 7-month high on Friday. Is this bond vigilantes&#39; warning and is ‘Santa Rally&#39; taking a pause?', 'created date': datetime.datetime(2024, 12, 30, 13, 13, 26, tzinfo=datetime.timezone.utc), 'symbols': ['DIA', 'IWM', 'QQQ', 'SPY']}
{'headline': 'Stifel Reiterates Buy on Codere Online Luxembourg, Maintains $10 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42720874/stifel-reiterates-buy-on-codere-online-luxembourg-maintains-10-price-target', 'summary': 'Stifel  analyst Jeffrey Stantial   reiterates Codere Online Luxembourg (NASDAQ:CDRO) with a Buy and maintains $10 price target.', 'created date': datetime.datetime(2024, 12, 30, 13, 13, 43, tzinfo=datetime.timezone.utc), 'symbols': ['CDRO']}
{'headline': 'MicroStrategy Says During Period Between December 23 And December 29, 2024, It Had Sold Aggregate Of 592,987 Shares Under Prior Sales Agreement For Aggregate Net Proceeds Of $209M', 'url': 'https://www.benzinga.com/news/24/12/42720875/microstrategy-says-during-period-between-december-23-and-december-29-2024-it-had-sold-aggregate-of-5', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 13, 44, tzinfo=datetime.timezone.utc), 'symbols': ['MSTR']}
{'headline': 'Cytek Biosciences Announces $50M Stock Buyback Program For 2025', 'url': 'https://www.benzinga.com/news/24/12/42720876/cytek-biosciences-announces-50m-stock-buyback-program-for-2025', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 13, 45, tzinfo=datetime.timezone.utc), 'symbols': ['CTKB']}
{'headline': 'Top 3 Tech Stocks That May Fall Off A Cliff This Quarter', 'url': 'https://www.benzinga.com/trading-ideas/short-ideas/24/12/42720878/top-3-tech-stocks-that-may-fall-off-a-cliff-this-quarter', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 13, 56, tzinfo=datetime.timezone.utc), 'symbols': ['MVIS', 'ONDS', 'ZENV']}
{'headline': 'MicroStrategy Says During Period Between December 23 And December 29, 2024, It Acquired Approximately 2,138 Bitcoins For $209M In Cash, At An Average Price Of $97,837 Per Bitcoin', 'url': 'https://www.benzinga.com/news/24/12/42720910/microstrategy-says-during-period-between-december-23-and-december-29-2024-it-acquired-approximately', 'summary': 'As of December\xa029, 2024, the Company, together with its subsidiaries, held an aggregate of approximately 446,400 bitcoins, which were acquired at an aggregate purchase price of approximately\xa0$27.9\xa0billion', 'created date': datetime.datetime(2024, 12, 30, 13, 14, 57, tzinfo=datetime.timezone.utc), 'symbols': ['MSTR']}
{'headline': 'Looking Into HCA Healthcare&#39;s Recent Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42720942/looking-into-hca-healthcares-recent-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 15, 14, tzinfo=datetime.timezone.utc), 'symbols': ['HCA']}
{'headline': 'How Is The Market Feeling About Robinhood Markets?', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42720943/how-is-the-market-feeling-about-robinhood-markets', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 15, 19, tzinfo=datetime.timezone.utc), 'symbols': ['HOOD']}
{'headline': 'Peering Into Evercore&#39;s Recent Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42720944/peering-into-evercores-recent-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 15, 24, tzinfo=datetime.timezone.utc), 'symbols': ['EVR']}
{'headline': 'What&#39;s Going On With Cel-Sci Shares Premarket On Monday?', 'url': 'https://www.benzinga.com/news/offerings/24/12/42721018/whats-going-on-with-cel-sci-shares-premarket-on-monday', 'summary': 'Cel-Sci announces public offering of 16.13M shares at $0.31 per share, aiming to raise $5M for Multikine development and general purposes.', 'created date': datetime.datetime(2024, 12, 30, 13, 21, 18, tzinfo=datetime.timezone.utc), 'symbols': ['CVM']}
{'headline': 'Needham Reiterates Buy on Axsome Therapeutics, Maintains $130 Price Target', 'url': 'https://www.benzinga.com/news/24/12/42721042/needham-reiterates-buy-on-axsome-therapeutics-maintains-130-price-target', 'summary': 'Needham  analyst Ami Fadia   reiterates Axsome Therapeutics (NASDAQ:AXSM) with a Buy and maintains $130 price target.', 'created date': datetime.datetime(2024, 12, 30, 13, 23, 41, tzinfo=datetime.timezone.utc), 'symbols': ['AXSM']}
{'headline': 'Palantir Stock Slips On Profit-Taking: Is It Time To Buy The Dip?', 'url': 'https://www.benzinga.com/trading-ideas/technicals/24/12/42721082/palantir-stock-slips-on-profit-taking-is-it-time-to-buy-the-dip', 'summary': 'PLTR stock is cooling off after a blistering 2024 run. The stock dipped 4.22% on Friday, followed by a 1.80% slide in pre-market trading Monday. Question: Buying opportunity or deeper correction?', 'created date': datetime.datetime(2024, 12, 30, 13, 25, 38, tzinfo=datetime.timezone.utc), 'symbols': ['MSFT', 'NVDA', 'PLTR', 'TSLA']}
{'headline': 'Mark Cuban Once Said Credit Card Users &#39;Don&#39;t Want To Be Rich.&#39; Now, US Credit Card Defaults Have Skyrocketed To Highest Levels Since 2008 Financial Crisis', 'url': 'https://www.benzinga.com/24/12/42721109/mark-cuban-once-said-credit-card-users-dont-want-to-be-rich-now-us-credit-card-defaults-have-skyrocketed-to-highest-levels-since-2008-financial-crisis', 'summary': 'U.S. credit card loan defaults have skyrocketed to levels unseen since the 2008 financial crisis. Credit card lenders wrote off a staggering $46 billion\xa0in seriously delinquent loan balances\xa0in the first nine months\xa0of 2024', 'created date': datetime.datetime(2024, 12, 30, 13, 26, 55, tzinfo=datetime.timezone.utc), 'symbols': ['COF']}
{'headline': '(PKG) - Analyzing Packaging Corp of America&#39;s Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42721256/pkg-analyzing-packaging-corp-of-americas-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 30, 15, tzinfo=datetime.timezone.utc), 'symbols': ['PKG']}
{'headline': 'Looking Into Insulet&#39;s Recent Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42721258/looking-into-insulets-recent-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 30, 19, tzinfo=datetime.timezone.utc), 'symbols': ['PODD']}
{'headline': '(CARR) - Analyzing Carrier Global&#39;s Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42721259/carr-analyzing-carrier-globals-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 30, 25, tzinfo=datetime.timezone.utc), 'symbols': ['CARR']}
{'headline': 'Microbot Medical Says It Concludes 2024 With Achievement Of Several Key Milestones, Including  Recent FDA 510(K) Submission For Commercial Approval Of LIBERTY', 'url': 'https://www.benzinga.com/news/24/12/42721310/microbot-medical-says-it-concludes-2024-with-achievement-of-several-key-milestones-including-recent', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 33, 22, tzinfo=datetime.timezone.utc), 'symbols': ['MBOT']}
{'headline': 'Tesla Stock Takes A Breather: Is The Rally Losing Charge?', 'url': 'https://www.benzinga.com/trading-ideas/technicals/24/12/42721312/tesla-stock-takes-a-breather-is-the-rally-losing-charge', 'summary': 'Tesla stock dips 4.95% on Friday and 1.35% on Monday after a strong year. Q4 delivery numbers and macro environment could impact its trajectory.', 'created date': datetime.datetime(2024, 12, 30, 13, 33, 57, tzinfo=datetime.timezone.utc), 'symbols': ['TSLA']}
{'headline': 'Autonomix Medical Announces US Patent Titled &#39;Systems and Methods for Treating Cancer and/or Augmenting Organ Function.&#39;', 'url': 'https://www.benzinga.com/general/biotech/24/12/42721313/autonomix-medical-announces-us-patent-titled-systems-and-methods-for-treating-cancer-andor-augmen', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 34, 2, tzinfo=datetime.timezone.utc), 'symbols': ['AMIX']}
{'headline': 'Inogen Receives FDA 510(K) Clearance For SIMEOX 200 Airway Clearance Device', 'url': 'https://www.benzinga.com/news/24/12/42721325/inogen-receives-fda-510-k-clearance-for-simeox-200-airway-clearance-device', 'summary': 'SIMEOX 200 is the next-generation of the original Simeox (currently available in select international markets). It is intended to promote and improve bronchial drainage by enhancing mobilization of bronchial secretions', 'created date': datetime.datetime(2024, 12, 30, 13, 34, 27, tzinfo=datetime.timezone.utc), 'symbols': ['INGN']}
{'headline': 'Brenmiller Energy Says bGen ZERO TES Has Been Selected To Anchor A Clean Energy Project Being Developed In Spain', 'url': 'https://www.benzinga.com/news/24/12/42721368/brenmiller-energy-says-bgen-zero-tes-has-been-selected-to-anchor-a-clean-energy-project-being-develo', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 35, 42, tzinfo=datetime.timezone.utc), 'symbols': ['BNRG']}
{'headline': 'SaverOne 2014 Secures Additional US Patent Strengthening IP Portfolio Underlying  Transportation Safety Solution', 'url': 'https://www.benzinga.com/news/24/12/42721381/saverone-2014-secures-additional-us-patent-strengthening-ip-portfolio-underlying-transportation-safe', 'summary': 'The patent, bearing the number 12,174,309 and issued on December 24, 2024, is entitled System and Methods for classifying a type of interaction between a human user and a mobile communication device in a volume based on', 'created date': datetime.datetime(2024, 12, 30, 13, 36, 58, tzinfo=datetime.timezone.utc), 'symbols': ['SVRE']}
{'headline': 'Nvidia Targets Robotics as Next Big Opportunity Amid Rising AI Rivalry', 'url': 'https://www.benzinga.com/media/24/12/42721414/nvidia-targets-robotics-as-next-big-opportunity-amid-rising-ai-rivalry', 'summary': 'Nvidia Corp is entering the robotics market to boost growth, competing with AMD, Amazon, and Google. Robotics could be its &#39;physical AI&#39; investment.', 'created date': datetime.datetime(2024, 12, 30, 13, 41, 18, tzinfo=datetime.timezone.utc), 'symbols': ['AAPL', 'AMD', 'AMZN', 'GOOG', 'GOOGL', 'JEPQ', 'NVDA', 'VT']}
{'headline': 'Roche CEO Reassures No Job Cuts Despite Challenges: Report', 'url': 'https://www.benzinga.com/24/12/42721437/roche-ceo-reassures-no-job-cuts-despite-drug-development-challenges-reports', 'summary': 'Roche Holding AG reportedly says no layoffs planned. CEO Schinecker provides pipeline updates including potential anti-obesity drug by 2029.', 'created date': datetime.datetime(2024, 12, 30, 13, 44, 2, tzinfo=datetime.timezone.utc), 'symbols': ['RHHBF', 'RHHBY']}
{'headline': 'Looking Into UFP Industries&#39;s Recent Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42721482/looking-into-ufp-industriess-recent-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 45, 15, tzinfo=datetime.timezone.utc), 'symbols': ['UFPI']}
{'headline': 'Looking Into AES&#39;s Recent Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42721483/looking-into-aess-recent-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 45, 20, tzinfo=datetime.timezone.utc), 'symbols': ['AES']}
{'headline': 'Peering Into Willis Towers Watson&#39;s Recent Short Interest', 'url': 'https://www.benzinga.com/insights/short-sellers/24/12/42721485/peering-into-willis-towers-watsons-recent-short-interest', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 13, 45, 25, tzinfo=datetime.timezone.utc), 'symbols': ['WTW']}
{'headline': 'Maxeon, Tongwei Solar Enter Settlement And Cross-licensing Agreement, Resolving Patent Infringement Lawsuit; No Terms Disclosed', 'url': 'https://www.benzinga.com/news/24/12/42721518/maxeon-tongwei-solar-enter-settlement-and-cross-licensing-agreement-resolving-patent-infringement-la', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 46, 48, tzinfo=datetime.timezone.utc), 'symbols': ['MAXN']}
{'headline': 'Apple&#39;s Chinese Rival Huawei Slashes Prices For New Year Boost: Should Tim Cook-Led Company Be Worried? Here&#39;s What Analysts Are Saying About AAPL Stock', 'url': 'https://www.benzinga.com/analyst-ratings/analyst-color/24/12/42721523/apples-chinese-rival-huawei-slashes-prices-for-new-year-boost-should-tim-cook-led-company-be-worried-heres-what-analysts-are-saying-about-aapl-stock', 'summary': 'Apple&#39;s Chinese rival Huawei announced heavy discounts on premium models, challenging the former&#39;s sales performance in this key market.', 'created date': datetime.datetime(2024, 12, 30, 13, 47, 3, tzinfo=datetime.timezone.utc), 'symbols': ['AAPL', 'QQQ']}
{'headline': 'Taiwan Semiconductor&#39;s Kaohsiung Expansion To Boost 2-nm Chip Production', 'url': 'https://www.benzinga.com/24/12/42721526/taiwan-semiconductors-kaohsiung-expansion-to-boost-jobs-and-2-nm-chip-production', 'summary': 'Taiwan Semiconductor plans to build two new wafer fabs in Kaohsiung by 2025, adding 8,000 jobs and commercializing advanced processes.', 'created date': datetime.datetime(2024, 12, 30, 13, 47, 25, tzinfo=datetime.timezone.utc), 'symbols': ['AMD', 'MU', 'NVDA', 'SOXQ', 'TSM', 'USD']}
{'headline': 'KULR Reveals Active Collaboration With US Army To Plan Evaluation Of KULR VIBE System For Vibration Reduction And Optimal Balance On AH-64E Apache And UH-60 Black Hawk Helicopters', 'url': 'https://www.benzinga.com/news/24/12/42721550/kulr-reveals-active-collaboration-with-us-army-to-plan-evaluation-of-kulr-vibe-system-for-vibration', 'summary': 'he evaluation is slated to begin in 2025 and will explore the potential of KULR VIBE to enhance operational efficiency and safety across these critical platforms.', 'created date': datetime.datetime(2024, 12, 30, 13, 48, 18, tzinfo=datetime.timezone.utc), 'symbols': ['KULR']}
{'headline': 'Sabra Health Care REIT, Amazon And More: CNBC&#39;s &#39;Final Trades&#39;', 'url': 'https://www.benzinga.com/24/12/42721551/amazon-sabra-health-care-reit-and-more-cnbcs-final-trades', 'summary': 'Jenny Van Leeuwen Harrington of Gilman Hill Asset Management picked Sabra Health Care REIT, Inc. as her final trade.', 'created date': datetime.datetime(2024, 12, 30, 13, 48, 25, tzinfo=datetime.timezone.utc), 'symbols': ['AMZN', 'IEO', 'SBRA']}
{'headline': 'Trading Halt: Halted at 8:50:00 a.m. ET - Trading Halt: Halt News Pending', 'url': 'https://www.benzinga.com/24/12/42721568/trading-halt-halted-at-8-50-00-a-m-et-trading-halt-halt-news-pending', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 50, 3, tzinfo=datetime.timezone.utc), 'symbols': ['VCSA']}
{'headline': 'VCI Global Invests In AI Startup Company Marvis Inc., A Delaware Corporation; Current Seed Funding Round Is Capped At Valuation Of $30M', 'url': 'https://www.benzinga.com/news/24/12/42721575/vci-global-invests-in-ai-startup-company-marvis-inc-a-delaware-corporation-current-seed-funding-roun', 'summary': 'This investment was made through a Simple Agreement for Future Equity (SAFE), which provided VC.AI to receive Marvis&#39; equity in the next financing round.\xa0The current seed funding round is capped at a valuation of', 'created date': datetime.datetime(2024, 12, 30, 13, 50, 22, tzinfo=datetime.timezone.utc), 'symbols': ['VCIG']}
{'headline': 'Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times', 'url': 'https://www.benzinga.com/24/12/42721606/trading-halt-halt-status-updated-at-8-55-00-am-et-quotation-resumption-news-and-resumption-times', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 13, 55, 4, tzinfo=datetime.timezone.utc), 'symbols': ['JNVR']}
{'headline': 'Telos Expands Locations To Enroll Consumers In TSA PreCheck Program By Opening 15 New Locations', 'url': 'https://www.benzinga.com/news/24/12/42721632/telos-expands-locations-to-enroll-consumers-in-tsa-precheck-program-by-opening-15-new-locations', 'summary': 'These locations began offering enrollment services today, December 30, 2024.', 'created date': datetime.datetime(2024, 12, 30, 13, 57, 5, tzinfo=datetime.timezone.utc), 'symbols': ['TLS']}
{'headline': 'Northland Capital Markets Maintains Outperform on Ondas Holdings, Raises Price Target to $4', 'url': 'https://www.benzinga.com/news/24/12/42721768/northland-capital-markets-maintains-outperform-on-ondas-holdings-raises-price-target-to-4', 'summary': 'Northland Capital Markets  analyst Michael Latimore   maintains Ondas Holdings (NASDAQ:ONDS) with a Outperform and raises the price target from $1.5 to $4.', 'created date': datetime.datetime(2024, 12, 30, 13, 59, 55, tzinfo=datetime.timezone.utc), 'symbols': ['ONDS']}
{'headline': '$100 Invested In Lowe&#39;s Companies 15 Years Ago Would Be Worth This Much Today', 'url': 'https://www.benzinga.com/insights/news/24/12/42721798/100-invested-in-lowes-companies-15-years-ago-would-be-worth-this-much-today', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 0, 12, tzinfo=datetime.timezone.utc), 'symbols': ['LOW']}
{'headline': 'Demystifying SkyWest: Insights From 4 Analyst Reviews', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42721800/demystifying-skywest-insights-from-4-analyst-reviews', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 0, 12, tzinfo=datetime.timezone.utc), 'symbols': ['SKYW']}
{'headline': 'Expert Outlook: Axsome Therapeutics Through The Eyes Of 8 Analysts', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42721820/expert-outlook-axsome-therapeutics-through-the-eyes-of-8-analysts', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 0, 21, tzinfo=datetime.timezone.utc), 'symbols': ['AXSM']}
{'headline': 'Analyst Expectations For Southwest Airlines&#39;s Future', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42721824/analyst-expectations-for-southwest-airliness-future', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 0, 28, tzinfo=datetime.timezone.utc), 'symbols': ['LUV']}
{'headline': 'Demystifying United Airlines Holdings: Insights From 16 Analyst Reviews', 'url': 'https://www.benzinga.com/insights/analyst-ratings/24/12/42721825/demystifying-united-airlines-holdings-insights-from-16-analyst-reviews', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 0, 35, tzinfo=datetime.timezone.utc), 'symbols': ['UAL']}
{'headline': 'MicroCloud Hologram Announces Development Of Semiconductor Quantum Dot Hole Spin Qubit Technology', 'url': 'https://www.benzinga.com/tech/24/12/42721842/microcloud-hologram-announces-development-of-semiconductor-quantum-dot-hole-spin-qubit-technology', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 1, 16, tzinfo=datetime.timezone.utc), 'symbols': ['HOLO']}
{'headline': 'Casago Agrees To Acquire All Outstanding Shares Of Vacasa Held By Public Stockholders At $5.02 Per Share', 'url': 'https://www.benzinga.com/m-a/24/12/42721867/casago-agrees-to-acquire-all-outstanding-shares-of-vacasa-held-by-public-stockholders-at-5-02-per-sh', 'summary': 'The per share purchase price represents a premium of 28 percent and 60 percent over Vacasa&#39;s 30-day and 90-day volume weighted average price per share, respectively, as of December 27, 2024, the last trading day prior to', 'created date': datetime.datetime(2024, 12, 30, 14, 2, 32, tzinfo=datetime.timezone.utc), 'symbols': ['VCSA']}
{'headline': 'The Information: ByteDance Planned to Spend $7 Billion on Nvidia Chips Next Year', 'url': 'https://www.benzinga.com/tech/24/12/42721874/the-information-bytedance-planned-to-spend-7-billion-on-nvidia-chips-next-year', 'summary': 'https://www.theinformation.com/articles/bytedance-planned-to-spend-7-billion-on-nvidia-chips-next-year', 'created date': datetime.datetime(2024, 12, 30, 14, 2, 53, tzinfo=datetime.timezone.utc), 'symbols': ['NVDA']}
{'headline': 'Here&#39;s How Much You Would Have Made Owning Lennox Intl Stock In The Last 5 Years', 'url': 'https://www.benzinga.com/insights/news/24/12/42722044/heres-how-much-you-would-have-made-owning-lennox-intl-stock-in-the-last-5-years', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 15, 11, tzinfo=datetime.timezone.utc), 'symbols': ['LII']}
{'headline': 'SuperCom Secured New Contracts with South Dakota Sheriff Agencies; Terms Not Disclosed', 'url': 'https://www.benzinga.com/news/24/12/42722099/supercom-secured-new-contracts-with-south-dakota-sheriff-agencies-terms-not-disclosed', 'summary': 'SuperCom (NASDAQ:\xa0SPCB),\xa0a global provider of secure solutions for the e-Government, IoT, and Cybersecurity sectors, announced today that it has secured multiple electronic monitoring contracts with county', 'created date': datetime.datetime(2024, 12, 30, 14, 16, 25, tzinfo=datetime.timezone.utc), 'symbols': ['SPCB']}
{'headline': 'AmpliTech Group Priced ~2..17M Share Registered Direct Offering @$4.60/Share', 'url': 'https://www.benzinga.com/news/24/12/42722118/amplitech-group-priced-2-17m-share-registered-direct-offering-4-60share', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 17, 31, tzinfo=datetime.timezone.utc), 'symbols': ['AMPG']}
{'headline': 'Lake Street Maintains Buy on TechTarget, Lowers Price Target to $24', 'url': 'https://www.benzinga.com/news/24/12/42722127/lake-street-maintains-buy-on-techtarget-lowers-price-target-to-24', 'summary': 'Lake Street  analyst Eric Martinuzzi   maintains TechTarget (NASDAQ:TTGT) with a Buy and lowers the price target from $36 to $24.', 'created date': datetime.datetime(2024, 12, 30, 14, 18, 35, tzinfo=datetime.timezone.utc), 'symbols': ['TTGT']}
{'headline': 'V2X Lands $170 Million DEA Contract To Combat Drug Trafficking; Stock Gains', 'url': 'https://www.benzinga.com/24/12/42722128/shares-of-v2x-climb-as-company-wins-170-million-dea-support-contract', 'summary': 'V2X secures $170 million contract with DEA to combat drug trafficking and support national security. ', 'created date': datetime.datetime(2024, 12, 30, 14, 18, 57, tzinfo=datetime.timezone.utc), 'symbols': ['PSN', 'VVX']}
{'headline': 'Silynxcom Secured Up To $2M Multi-Year Contract for Advanced In-Ear Communication Systems To Finnish Police', 'url': 'https://www.benzinga.com/news/24/12/42722138/silynxcom-secured-up-to-2m-multi-year-contract-for-advanced-in-ear-communication-systems-to-finnish', 'summary': 'Silynxcom Ltd. (NYSE:SYNX) (&#34;Silynxcom&#34; or the &#34;Company&#34;), a manufacturer and developer of ruggedized tactical communication headset devices, announced today that it had signed a four-year framework contract, facilitated', 'created date': datetime.datetime(2024, 12, 30, 14, 19, 17, tzinfo=datetime.timezone.utc), 'symbols': ['SYNX']}
{'headline': 'C3is Announced 1-for-2.5 Reverse Stock Split, Effective Dec 31, 2024', 'url': 'https://www.benzinga.com/news/24/12/42722172/c3is-announced-1-for-2-5-reverse-stock-split-effective-dec-31-2024', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 22, 54, tzinfo=datetime.timezone.utc), 'symbols': ['CISS']}
{'headline': 'Greenwave Technology Solutions Projects $43M-$45M Revenue In FY 2025; Domestic Sales Projected To Rise From 41% To  75% In 2025', 'url': 'https://www.benzinga.com/news/24/12/42722229/greenwave-technology-solutions-projects-43m-45m-revenue-in-fy-2025-domestic-sales-projected-to-rise', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 26, 35, tzinfo=datetime.timezone.utc), 'symbols': ['GWAV']}
{'headline': 'Why Is White Label Technology Company SMX Stock Surging On Monday?', 'url': 'https://www.benzinga.com/24/12/42722231/why-information-technology-company-smx-shares-are-surging-on-monday', 'summary': 'SMX shares rise premarket as their innovative technology of digital twins and blockchain supports circular economy and improves supply chain traceability.', 'created date': datetime.datetime(2024, 12, 30, 14, 27, 9, tzinfo=datetime.timezone.utc), 'symbols': ['SMX']}
{'headline': 'Geopark Said Unable To Proceed With CPO-9 Block Acquisition', 'url': 'https://www.benzinga.com/m-a/24/12/42722240/geopark-said-unable-to-proceed-with-cpo-9-block-acquisition', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 27, 30, tzinfo=datetime.timezone.utc), 'symbols': ['GPRK']}
{'headline': 'Polar Power Regains Compliance With Minimum Bid Price Requirement Set Forth By Nasdaq Stock Market', 'url': 'https://www.benzinga.com/news/24/12/42722363/polar-power-regains-compliance-with-minimum-bid-price-requirement-set-forth-by-nasdaq-stock-market', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 28, 7, tzinfo=datetime.timezone.utc), 'symbols': ['POLA']}
{'headline': 'How To Earn $500 A Month From UniFirst Stock Ahead Of Q1 Earnings', 'url': 'https://www.benzinga.com/news/earnings/24/12/42722387/how-to-earn-500-a-month-from-unifirst-stock-ahead-of-q1-earnings', 'summary': 'UniFirst offers an annual dividend yield of 0.81%. Investors can exploit its dividend yield to pocket a regular $500 monthly', 'created date': datetime.datetime(2024, 12, 30, 14, 29, 54, tzinfo=datetime.timezone.utc), 'symbols': ['UNF']}
{'headline': 'Here&#39;s How Much $1000 Invested In FTAI Aviation 5 Years Ago Would Be Worth Today', 'url': 'https://www.benzinga.com/insights/news/24/12/42722397/heres-how-much-1000-invested-in-ftai-aviation-5-years-ago-would-be-worth-today', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 30, 10, tzinfo=datetime.timezone.utc), 'symbols': ['FTAI']}
{'headline': 'LiveOne Says It Reached A Milestone Of 450,000+ Tesla Users', 'url': 'https://www.benzinga.com/news/24/12/42722419/liveone-says-it-reached-a-milestone-of-450-000-tesla-users', 'summary': 'Of those users, over 100,000 are free ad-supported users, with data showing that on average such users spend 50+ minutes of in-vehicle listening daily.', 'created date': datetime.datetime(2024, 12, 30, 14, 31, 4, tzinfo=datetime.timezone.utc), 'symbols': ['LVO']}
{'headline': 'Knightscope Says Seven Clients Have Renewed Their Agreements For Its Autonomous Security Robot And Emergency Communication Device Services', 'url': 'https://www.benzinga.com/news/24/12/42722554/knightscope-says-seven-clients-have-renewed-their-agreements-for-its-autonomous-security-robot-and-e', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 36, 35, tzinfo=datetime.timezone.utc), 'symbols': ['KSCP']}
{'headline': 'Trading Halt: Halt status updated at 9:45:00 AM ET: Quotation Resumption: News and Resumption Times', 'url': 'https://www.benzinga.com/24/12/42722823/trading-halt-halt-status-updated-at-9-45-00-am-et-quotation-resumption-news-and-resumption-times', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 45, 6, tzinfo=datetime.timezone.utc), 'symbols': ['VCSA']}
{'headline': 'Here&#39;s How Much You Would Have Made Owning Viking Therapeutics Stock In The Last 5 Years', 'url': 'https://www.benzinga.com/insights/news/24/12/42722826/heres-how-much-you-would-have-made-owning-viking-therapeutics-stock-in-the-last-5-years', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 45, 13, tzinfo=datetime.timezone.utc), 'symbols': ['VKTX']}
{'headline': 'Market Whales and Their Recent Bets on Micron Technology Options', 'url': 'https://www.benzinga.com/insights/options/24/12/42722860/market-whales-and-their-recent-bets-on-micron-technology-options', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 45, 39, tzinfo=datetime.timezone.utc), 'symbols': ['MU']}
{'headline': 'This Is What Whales Are Betting On Advanced Micro Devices', 'url': 'https://www.benzinga.com/insights/options/24/12/42722864/this-is-what-whales-are-betting-on-advanced-micro-devices', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 45, 44, tzinfo=datetime.timezone.utc), 'symbols': ['AMD']}
{'headline': 'MARA Holdings&#39;s Options Frenzy: What You Need to Know', 'url': 'https://www.benzinga.com/insights/options/24/12/42722866/mara-holdingss-options-frenzy-what-you-need-to-know', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 45, 49, tzinfo=datetime.timezone.utc), 'symbols': ['MARA']}
{'headline': 'Chicago PMI (Dec) 36.9\tvs 42.7 Est.', 'url': 'https://www.benzinga.com/economics/macro-economic-events/24/12/42722896/chicago-pmi-dec-36-9-vs-42-7-est', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 14, 46, 38, tzinfo=datetime.timezone.utc), 'symbols': ['SPY']}
{'headline': 'This American Airlines Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday', 'url': 'https://www.benzinga.com/analyst-ratings/upgrades/24/12/42722934/this-american-airlines-analyst-turns-bullish-here-are-top-3-upgrades-for-monday', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 47, 27, tzinfo=datetime.timezone.utc), 'symbols': ['AAL', 'ARQT', 'ARTV', 'CTXR', 'NUVL']}
{'headline': 'Bitcoin May Exceed $250K Amid Halving And US Adoption; Taiwan Semi Expands 2-nm Chips; Boeing Drops On Crash Scrutiny - Top Headlines Today While US Slept', 'url': 'https://www.benzinga.com/24/12/42723114/bitcoin-may-exceed-250k-amid-halving-and-us-adoption-taiwan-semi-expands-2-nm-chips-boeing-drops-on-crash-scrutiny-top-headlines-today-while-us-slept', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 14, 53, 23, tzinfo=datetime.timezone.utc), 'symbols': ['BTCUSD', 'ETHUSD', 'SPY']}
{'headline': 'US Pending Home Sales (MoM) (Nov) +2.2% vs +0.9% Est.', 'url': 'https://www.benzinga.com/economics/macro-economic-events/24/12/42723470/us-pending-home-sales-mom-nov-2-2-vs-0-9-est', 'summary': '', 'created date': datetime.datetime(2024, 12, 30, 15, 0, 9, tzinfo=datetime.timezone.utc), 'symbols': ['SPY']}
{'headline': 'XRP Down More Than 6% Within 24 hours', 'url': 'https://www.benzinga.com/insights/cryptocurrency/24/12/42723476/xrp-down-more-than-6-within-24-hours', 'summary': 'Over the past 24 hours, XRP&#39;s (CRYPTO: XRP) price has fallen 6.9% to $2.01. This continues its negative trend over the past week where it has experienced a 6.0% loss, moving from $2.15 to its current price. ', 'created date': datetime.datetime(2024, 12, 30, 15, 0, 11, tzinfo=datetime.timezone.utc), 'symbols': ['XRPUSD']}
{'headline': 'Analyzing NVIDIA In Comparison To Competitors In Semiconductors &amp; Semiconductor Equipment Industry', 'url': 'https://www.benzinga.com/insights/news/24/12/42723479/analyzing-nvidia-in-comparison-to-competitors-in-semiconductors-amp-semiconductor-equipment-industr', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 15, 0, 13, tzinfo=datetime.timezone.utc), 'symbols': ['NVDA']}
{'headline': '$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today', 'url': 'https://www.benzinga.com/insights/news/24/12/42723480/1000-invested-in-this-stock-5-years-ago-would-be-worth-this-much-today', 'summary': ' ', 'created date': datetime.datetime(2024, 12, 30, 15, 0, 14, tzinfo=datetime.timezone.utc), 'symbols': ['NUE']}
